Purchase Order 75N91019P00735

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480.00 on March 30, 2020, with performance completion by March 31, 2021. Work is performed in Bethesda, Maryland. This firm fixed-price purchase order acquired molecular diagnostics products or services—specific scope details are not provided in the award documentation.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480 on June 9, 2020, with an ultimate completion date of June 14, 2021. Work is performed in Germantown, Maryland. The order is firm fixed price with no set-aside category. No additional source material specifies the scope of services or supplies procured under this purchase order.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for a QCI subscription valued at $24,000.00 on December 17, 2019, with ultimate completion on July 1, 2020. Place of performance is Germantown, Maryland. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $8,337.35 on April 16, 2018, with an ultimate completion date of May 12, 2018. Work is performed in Valencia, California. The order is priced as firm fixed price with no set-aside. The specific requirements are not detailed in the source.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC valued at $3,684.00 on June 27, 2017, with an ultimate completion date of June 23, 2018. Performance occurs in Bethesda, Maryland. The order is priced on a firm fixed price basis with no set-aside designation applied.</p>

The National Cancer Institute awarded a purchase order to Qiagen, LLC for $4,995.00 on January 26, 2018, with completion scheduled for January 31, 2019. No set-aside was used. Performance takes place in Bethesda, Maryland. The order calls for firm fixed-price procurement of molecular diagnostics, scientific equipment, or bioinformatics solutions consistent with Qiagen's federal product portfolio of DNA and RNA extraction kits, next-generation sequencing supplies, sample preparation...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for laboratory supplies valued at $4,368.70 on July 6, 2017, with an ultimate completion date of August 4, 2017. Work is performed in Germantown, Maryland. The order is for QIAGEN lab supplies on a firm fixed price basis with no set-aside used.</p>

The National Cancer Institute awarded a purchase order to Qiagen, LLC for scientific equipment on August 24, 2021, with a ceiling value of $24,930.00 and a firm fixed price. The order was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability. Place of performance is Germantown, Maryland. The ultimate completion date is December 31, 2021....

<p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>

<p>The National Cancer Institute issued a purchase order to Qiagen, LLC for sample testing with a ceiling value of $24,000.00 on July 17, 2019. Performance occurs at Bethesda, MD 20892. The order carries firm fixed price pricing and is scheduled for ultimate completion July 19, 2020. No set-aside was used.</p>